Vascular disease in diabetic women: Why do they miss the female protection?

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Dantas, Ana Paula Villela ^a   Fortes, Zuleica Bruno ^b   De Carvalho, Maria Helena Catelli ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSINOGEN; ENDOTHELIN 1; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FATTY ACID; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN; PROSTAGLANDIN H2; PROTEIN KINASE B; SEX HORMONE; STRESS ACTIVATED PROTEIN KINASE; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; DIABETOGENESIS; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; ESTROGEN THERAPY; FEMALE; GENETIC RISK; HORMONE SUBSTITUTION; HUMAN; HYPERGLYCEMIA; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTECTION; REVIEW; SEX DIFFERENCE; SMOKING; THROMBOSIS; VASOCONSTRICTION; AGED; ANIMAL; MALE; RISK FACTOR; VASCULAR DISEASE; WOMEN'S HEALTH;

AGED; ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; RISK FACTORS; SEX FACTORS; VASCULAR DISEASES; WOMEN'S HEALTH;

EID: 84867006563     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/570598     Document Type: Review

References (108)

1. Creager M. A., Lüscher T. F., Cosentino F., Beckman J. A., Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003 108 12 1527 1532 2-s2.0-0141615827 10.1161/01.CIR.0000091257.27563.32
2. Lüscher T. F., Creager M. A., Beckman J. A., Cosentino F., Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part II. Circulation 2003 108 13 1655 1661 2-s2.0-0141730235 10.1161/01.CIR.0000089189.70578.E2
3. Akamine E. H., Kawamoto E. M., Scavone C., Nigro D., Carvalho M. H. C., Tostes R. D. C. A., Britto L. R. G., Fortes Z. B., Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin. Journal of Vascular Research 2006 43 4 309 320 2-s2.0-33746662917 10.1159/000093196
4. Rastelli V. M. F., Akamine E. H., Oliveira M. A., Nigro D., De Cássia Tostes Passaglia R., Catelli Carvalho M. H., Fortes Z. B., Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. Inflammation Research 2005 54 4 173 179 2-s2.0-23844493087 10.1007/s00011-004-1339-0
5. Schindler T. H., Facta A. D., Prior J. O., Cadenas J., Hsueh W. A., Quinones M. J., Schelbert H. R., Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. Heart 2007 93 3 345 349 2-s2.0-34147210397 10.1136/hrt.2006.094128
6. Yamagishi S. I., Maeda S., Matsui T., Ueda S., Fukami K., Okuda S., Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochimica et Biophysica Acta 2011 1820 5 663 671 2-s2.0-79955095288 10.1016/j.bbagen.2011.03.014
7. Farmer D. G. S., Kennedy S., RAGE, vascular tone and vascular disease. Pharmacology and Therapeutics 2009 124 2 185 194 2-s2.0-70349161964 10.1016/j.pharmthera.2009.06.013
8. Lander H. M., Tauras J. M., Ogiste J. S., Hori O., Moss R. A., Schmidt A. M., Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. The Journal of Biological Chemistry 1997 272 28 17810 17814 2-s2.0-0030859290 10.1074/jbc.272.28.17810
9. Rial N. S., Choi K., Nguyen T., Snyder B., Slepian M. J., Nuclear factor kappa B, (NF- κ B): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion? Medical Hypotheses 2012 78 1 29 32 10.1016/j.mehy.2011.09.034
10. Hsueh W. A., Lyon C. J., Quiones M. J., Insulin resistance and the endothelium. American Journal of Medicine 2004 117 2 109 117 2-s2.0-3242695011 10.1016/j.amjmed.2004.02.042
11. Caballero A. E., Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obesity Research 2003 11 11 1278 1289 2-s2.0-1542545604
12. Zeng G., Nystrom F. H., Ravichandran L. V., Cong L. N., Kirby M., Mostowski H., Quon M. J., Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000 101 13 1539 1545 2-s2.0-0034603858
13. Zeng G., Quon M. J., Insulin-stimulated production of nitric oxide is inhibited by Wortmannin: direct measurement in vascular endothelial cells. Journal of Clinical Investigation 1996 98 4 894 898 2-s2.0-0029789432
14. Wang C. C. L., Goalstone M. L., Draznin B., Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 2004 53 11 2735 2740 2-s2.0-7044263120 10.2337/diabetes.53.11.2735
15. Taguchi K., Matsumoto T., Kamata K., Kobayashi T., Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic mice. Pharmacological Research 2012 65 1 56 65 10.1016/j.phrs.2011.08.009
16. Taguchi K., Kobayashi T., Matsumoto T., Kamata K., Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/Akt activation in aortas of ob/ob mice. American Journal of PhysiologyHeart and Circulatory Physiology 2011 301 2 H571 H583 2-s2.0-79961038726 10.1152/ajpheart.01189.2010
17. Montagnani M., Golovchenko I., Kim I., Koh G. Y., Goalstone M. L., Mundhekar A. N., Johansen M., Kucik D. F., Quon M. J., Draznin B., Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. The Journal of Biological Chemistry 2002 277 3 1794 1799 2-s2.0-18544363627 10.1074/jbc.M103728200
18. Gogg S., Smith U., Jansson P. A., Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1. Diabetes 2009 58 10 2238 2245 2-s2.0-70349648329 10.2337/db08-0961
19. Oliver F. J., de la Rubia G., Feener E. P., Lee M. E., Loeken M. R., Shiba T., Quertermous T., King G. L., Stimulation of endothelin-1 gene expression by insulin in endothelial cells. The Journal of Biological Chemistry 1991 266 34 23251 23256 2-s2.0-0026325881
20. Roos C. J., Quax P. H., Jukema J. W., Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease. Biomarkers in Medicine 2012 6 1 35 52 10.2217/bmm.11.105
21. Gomes F., Telo D. F., Souza H. P., Nicolau J. C., Halpern A., Serrano C. V., Obesity and coronary artery disease: role of vascular inflammation. Arquivos Brasileiros de Cardiologia 2010 94 2 255 266 2-s2.0-77951983009
22. de Carvalho M. H., Colaco A. L., Fortes Z. B., Cytokines, endothelial dysfunction, and insulin resistance. Arquivos Brasileiros de Endocrinologia & Metabologia 2006 50 2 304 312
23. Swarbrick M. M., Havel P. J., Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metabolic Syndrome and Related Disorders 2008 6 2 87 102 2-s2.0-44449111714 10.1089/met.2007.0029
24. Lobato N. S., Filgueira F. P., Akamine E. H., Tostes R. C., Carvalho M. H., Mechanisms of endothelial dysfunction in obesity-associated hypertension. Brazilian Journal of Medical and Biological Research 2012 45 5 392 400 10.1590/S0100-879X2012007500058
25. Maenhaut N., van de Voorde J., Regulation of vascular tone by adipocytes. BMC Medicine 2011 9, article 25 2-s2.0-79952709927 10.1186/1741-7015-9-25
26. Hanzu F. A., Palomo M., Kalko S. G., Parrizas M., Garaulet M., Escolar G., Gomis R., Diaz-Ricart M., Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses. Journal of Thrombosis and Haemostasis 2011 9 6 1236 1245 2-s2.0-79958052174 10.1111/j.1538-7836.2011.04285.x
27. Messerli F. H., Garavaglia G. E., Schmieder R. E., Disparate cardiovascular findings in men and women with essential hypertension. Annals of Internal Medicine 1987 107 2 158 161 2-s2.0-0023615821
28. Bairey Merz C. N., Shaw L. J., Reis S. E., Bittner V., Kelsey S. F., Olson M., Johnson B. D., Pepine C. J., Mankad S., Sharaf B. L., Rogers W. J., Pohost G. M., Lerman A., Quyyumi A. A., Sopko G., Insights from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study. Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. Journal of the American College of Cardiology 2006 47 3, supplement S21 S29 2-s2.0-31644449009 10.1016/j.jacc.2004.12.084
29. Shaw L. J., Bairey Merz C. N., Pepine C. J., Reis S. E., Bittner V., Kelsey S. F., Olson M., Johnson B. D., Mankad S., Sharaf B. L., Rogers W. J., Wessel T. R., Arant C. B., Pohost G. M., Lerman A., Quyyumi A. A., Sopko G., Insights from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study. Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. Journal of the American College of Cardiology 2006 47 3, supplement S4 S20 2-s2.0-31644443751 10.1016/j.jacc.2005.01.072
30. Pencina M. J., D'Agostino R. B. Sr., Larson M. G., Massaro J. M., Vasan R. S., Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation 2009 119 24 3078 3084 2-s2.0-67649516627 10.1161/CIRCULATIONAHA.108.816694
31. Anand S. S., Islam S., Rosengren A., Franzosi M. G., Steyn K., Yusufali A. H., Keltai M., Diaz R., Rangarajan S., Yusuf S., Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. European Heart Journal 2008 29 7 932 940 2-s2.0-41849150370 10.1093/eurheartj/ehn018
32. Yusuf S., Hawken S., Ounpuu S., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 2004 364 9438 937 952
33. Chen Y. F., Meng Q. C., Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sciences 1991 48 1 85 96 2-s2.0-0026074118 10.1016/0024-3205(91)90428-E
34. Ouchi Y., Share L., Crofton J. T., Sex difference in the development of deoxycorticosterone-salt hypertension in the rat. Hypertension 1987 9 2 172 177 2-s2.0-0023100034
35. Rowland N. E., Fregly M. J., Role of gonadal hormones in hypertension in the Dahl salt-sensitive rat. Clinical and Experimental HypertensionPart A 1992 14 3 367 375 2-s2.0-0026577144
36. Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J., Global burden of hypertension: analysis of worldwide data. The Lancet 2005 365 9455 217 223 2-s2.0-12344282783 10.1016/S0140-6736(05)17741-1
37. D'Agostino R. B. Sr., Vasan R. S., Pencina M. J., Wolf P. A., Cobain M., Massaro J. M., Kannel W. B., General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008 117 6 743 753 2-s2.0-39549093148 10.1161/CIRCULATIONAHA.107.699579
38. Burt V. L., Whelton P., Roccella E. J., Brown C., Cutler J. A., Higgins M., Horan M. J., Labarthe D., Prevalence of hypertension in the US adult population: results from the third national health and nutrition examination survey, 19881991. Hypertension 1995 25 3 305 313 2-s2.0-0028942436
39. Stamler J., Stamler R., Riedlinger W. F., Algera G., Roberts R. H., Hypertension screening of 1 million Americans. Community hypertension evaluation clinic (CHEC) program, 1973 through 1975. The Journal of the American Medical Association 1976 235 21 2299 2306 2-s2.0-0017314648 10.1001/jama.235.21.2299
40. Flegal K. M., Ogden C. L., Carroll M. D., Prevalence and trends in overweight in Mexican-American adults and children. Nutrition Reviews 2004 62 7 S144 S148 2-s2.0-4043059511
41. Cutler J. A., Sorlie P. D., Wolz M., Thom T., Fields L. E., Roccella E. J., Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 19881994 and 19992004. Hypertension 2008 52 5 818 827 2-s2.0-55949126144 10.1161/HYPERTENSIONAHA.108.113357
42. Tostes R. C., Nigro D., Fortes Z. B., Carvalho M. H. C., Effects of estrogen on the vascular system. Brazilian Journal of Medical and Biological Research 2003 36 9 1143 1158 2-s2.0-0141920448
43. Frink R. J., Gender gap, inflammation and acute coronary disease: are women resistant to atheroma growth? Observations at autopsy. Journal of Invasive Cardiology 2009 21 6 270 277 2-s2.0-69249135029
44. Lansky A. J., Ng V. G., Maehara A., Weisz G., Lerman A., Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC: Cardiovasc Imaging 2012 5 3, supplement S62 S72 10.1016/j.jcmg.2012.02.003
45. Pereira T. M. C., Nogueira B. V., Lima L. C. F., Porto M. L., Arruda J. A., Vasquez E. C., Meyrelles S. S., Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids in Health and Disease 2010 9, article 87 2-s2.0-77955682572 10.1186/1476-511X-9-87
46. Surra J. C., Guillén N., Arbonés-Mainar J. M., Barranquero C., Navarro M. A., Arnal C., Orman I., Segovia J. C., Osada J., Sex as a profound modifier of atherosclerotic lesion development in apolipoprotein E-deficient mice with different genetic backgrounds. Journal of Atherosclerosis and Thrombosis 2010 17 7 712 721 2-s2.0-77955791931
47. Holm P., Andersen H. L., Arroe G., Stender S., Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbits: role of the endothelium and mononuclear-endothelial cell interaction. Circulation 1998 98 24 2731 2737 2-s2.0-0032534454
48. Bolego C., Poli A., Paoletti R., Smoking and gender. Cardiovascular Research 2002 53 3 568 576 2-s2.0-0037083849 10.1016/S0008-6363(01)00520-X
49. Oparil S., Pathophysiology of sudden coronary death in women: implications for prevention. Circulation 1998 97 21 2103 2105 2-s2.0-0032474470
50. Seltzer C. C., The negative association in women between cigarette smoking and uncomplicated angina pectoris in the Framingham heart study data. Journal of Clinical Epidemiology 1991 44 9 871 880 2-s2.0-0025871466 10.1016/0895-4356(91)90047-D
51. Seltzer C. C., Framingham study data and established wisdom about cigarette smoking and coronary heart disease. Journal of Clinical Epidemiology 1989 42 8 743 750 2-s2.0-0024396234
52. Hammond E. C., Smoking in relation to the death rates of one million men and women. National Cancer Institute Monograph 1966 19 127 204 2-s2.0-0013867186
53. Doll R., Peto R., Wheatley K., Gray R., Sutherland I., Mortality in relation to smoking: 40 years' observations on male British doctors. British Medical Journal 1994 309 6959 901 911 2-s2.0-0028168904
54. Tanasescu M., Cho E., Manson J. E., Hu F. B., Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. American Journal of Clinical Nutrition 2004 79 6 999 1005 2-s2.0-3042842675
55. Huxley R., Barzi F., Woodward M., Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. British Medical Journal 2006 332 7533 73 78 2-s2.0-30744433885 10.1136/bmj.38678.389583.7C
56. Franconi F., Seghieri G., Canu S., Straface E., Campesi I., Malorni W., Are the available experimental models of type 2 diabetes appropriate for a gender perspective? Pharmacological Research 2008 57 1 6 18 2-s2.0-39149104626 10.1016/j.phrs.2007.11.007
57. Takenouchi Y., Kobayashi T., Taguchi K., Matsumoto T., Kamata K., Gender differences in endothelial function in aortas from type 2 diabetic model mice. Journal of Pharmacological Sciences 2009 111 1 91 99 2-s2.0-70349510450 10.1254/jphs.09133FP
58. Takenouchi Y., Kobayashi T., Taguchi K., Matsumoto T., Kamata K., Gender differences in vascular reactivity of aortas from streptozotocin-induced diabetic mice. Biological and Pharmaceutical Bulletin 2010 33 10 1692 1697 2-s2.0-77957982225
59. Toledo D. P., Akamine E., Nigro D., Passaglia R. C. T., Carvalho M. H. C., Fortes Z. B., Microvascular reactivity in experimental diabetes: responses of male and female rats. Inflammation Research 2003 52 5 191 198 2-s2.0-0037837035
60. Rees D. A., Alcolado J. C., Animal models of diabetes mellitus. Diabetic Medicine 2005 22 4 359 370 2-s2.0-17144404203 10.1111/j.1464-5491.2005.01499.x
61. Plum L., Wunderlich F. T., Baudler S., Krone W., Brüning J. C., Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives. Physiology 2005 20 3 152 161 2-s2.0-20444376132 10.1152/physiol.00049.2004
62. Teede H. J., Sex hormones and the cardiovascular system: effects on arterial function in women. Clinical and Experimental Pharmacology and Physiology 2007 34 7 672 676 2-s2.0-34250772239 10.1111/j.1440-1681.2007.04658.x
63. Silva-Antonialli M. M., Fortes Z. B., Carvalho M. H. C., Scivoletto R., Nigro D., Sexual dimorphism in the response of thoracic aorta from SHRs to losartan. General Pharmacology: The Vascular System 2000 34 5 329 335 2-s2.0-0034444872 10.1016/S0306-3623(00)00078-1
64. Dantas A. P. V., Franco M. D. C. P., Tostes R. C. A., Fortes Z. B., Costa S. G., Nigro D., Carvalho M. H. C., Relative contribution of estrogen withdrawal and gonadotropins increase secondary to ovariectomy on prostaglandin generation in mesenteric microvessels. Journal of Cardiovascular Pharmacology 2004 43 1 48 55 2-s2.0-0347594035 10.1097/00005344-200401000-00008
65. Dantas A. P. V., Scivoletto R., Fortes Z. B., Nigro D., Carvalho M. H. C., Influence of female sex hormones on endothelium-derived vasoconstrictor prostanoid generation in microvessels of spontaneously hypertensive rats. Hypertension 1999 34 4 914 919 2-s2.0-0032729480
66. WHO, Burden: mortality, morbidity and risk factors. Global Status Report on Noncommunicable Diseases 2010 2011 chapter 1 9 31
67. Staessen J., Bulpitt C. J., Fagard R., Lijnen P., Amery A., The influence of menopause on blood pressure. Journal of Human Hypertension 1989 3 6 427 433 2-s2.0-0024811747
68. Dantas A. P. V., Tostes R. C. A., Fortes Z. B., Costa S. G., Nigro D., Carvalho M. H. C., In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002 39 2 405 411 2-s2.0-0036178170 10.1161/hy0202.102993
69. Hinojosa-Laborde C., Craig T., Zheng W., Ji H., Haywood J. R., Sandberg K., Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 2004 44 4 405 409 2-s2.0-4644297107 10.1161/01.HYP.0000142893. 08655.96
70. Miller V. M., Duckles S. P., Vascular actions of estrogens: functional implications. Pharmacological Reviews 2008 60 2 210 241 2-s2.0-46949109892 10.1124/pr.107.08002
71. Couse J. F., Lindzey J., Grandien K., Gustafsson J. A., Korach K. S., Tissue distribution and quantitative analysis of estrogen receptor- α (ER α) and estrogen receptor- β (ER β) messenger ribonucleic acid in the wild-type and ER α -knockout mouse. Endocrinology 1997 138 11 4613 4621 2-s2.0-0030728930 10.1210/en.138.11.4613
72. Pau C. Y., Pau K. Y. F., Spies H. G., Putative estrogen receptor β and α mRNA expression in male and female rhesus macaques. Molecular and Cellular Endocrinology 1998 146 1-2 59 68 2-s2.0-0032567220 10.1016/S0303- 7207(98)00197-X
73. The Writing Group for the PT, Miller V. T., LaRosa J., Barnabei V., Kessler C., Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial. The Journal of the American Medical Association 1995 273 3 199 208
74. Tolbert T., Thompson J. A., Bouchard P., Oparil S., Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model. Circulation 2001 104 22 2740 2745 2-s2.0-0035960664
75. Chandrasekar B., Sirois M. G., Geoffroy P., Lauzier D., Nattel S., Tanguay J. F., Local delivery of 17 β -estradiol improves reendothelialization and decreases inflammation after coronary stenting in a porcine model. Thrombosis and Haemostasis 2005 94 5 1042 1047 2-s2.0-27844607407 10.1160/TH04-12-0823
76. Chandrasekar B., Nattel S., Tanguay J. F., Coronary artery endothelial protection after local delivery of 17 β -estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function. Journal of the American College of Cardiology 2001 38 5 1570 1576 2-s2.0-0035498970 10.1016/S0735-1097(01)01552-2
77. Chandrasekar B., Tanguay J. F., Local delivery of 17-beta-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model. Journal of the American College of Cardiology 2000 36 6 1972 1978 2-s2.0-0034669450 10.1016/S0735-1097(00)00940-2
78. Novensa L., Selent J., Pastor M., Sandberg K., Heras M., Dantas A. P., Equine estrogens impair nitric oxide production and endothelial nitric oxide synthase transcription in human endothelial cells compared with the natural 17 β -estradiol. Hypertension 2010 56 3 405 411 2-s2.0-77955984016 10.1161/HYPERTENSIONAHA.110.151969
79. Sobrino A., Mata M., Laguna-Fernandez A., Novella S., Oviedo P. J., García-Pérez M. A., Tarín J. J., Cano A., Hermenegildo C., Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells. PloS one 2009 4 12 e8242 2-s2.0-77949518232
80. Sobrino A., Oviedo P. J., Novella S., Laguna-Fernandez A., Bueno C., García-Pérez M. A., Tarín J. J., Cano A., Hermenegildo C., Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor- α Journal of Molecular Endocrinology 2010 44 4 237 246 2-s2.0-77950209694 10.1677/JME-09-0112
81. Golding E. M., Kepler T. E., Role of estrogen in modulating EDHF-mediated dilations in the female rat middle cerebral artery. American Journal of PhysiologyHeart and Circulatory Physiology 2001 280 6 H2417 H2423 2-s2.0-0034991492
82. Novella S., Dantas A. P., Segarra G., Novensà L., Bueno C., Heras M., Hermenegildo C., Medina P., Gathering of aging and estrogen withdrawal in vascular dysfunction of senescent accelerated mice. Experimental Gerontology 2010 45 11 868 874 2-s2.0-77957782794 10.1016/j.exger.2010.07.007
83. Davidge S. T., Zhang Y., Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Circulation Research 1998 83 4 388 395 2-s2.0-0032563713
84. David F. L., Carvalho M. H., Cobra A. L., Nigro D., Fortes Z. B., Rebouas N. A., Tostes R. C., Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 2001 38 3 692 696 2-s2.0-0035462242
85. Kip K. E., Marroquin O. C., Shaw L. J., Arant C. B., Wessel T. R., Olson M. B., Johnson B. D., Mulukutla S., Sopko G., Merz C. N. B., Reis S. E., Global inflammation predicts cardiovascular risk in women: a report from the women's ischemia syndrome evaluation (WISE) study. American Heart Journal 2005 150 5 900 906 2-s2.0-27744574659 10.1016/j.ahj.2005.02.002
86. Sumino H., Ichikawa S., Ohyama Y., Takahashi T., Saito Y., Nakamura T., Kanda T., Kurabayashi M., Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women. American Journal of Cardiology 2005 96 1 148 153 2-s2.0-20744446634 10.1016/j.amjcard.2005.02.059
87. Friedrich E. B., Clever Y. P., Wassmann S., Hess C., Nickenig G., 17 β -estradiol inhibits monocyte adhesion via down-regulation of Rac1 GTPase. Journal of Molecular and Cellular Cardiology 2006 40 1 87 95 2-s2.0-29444435876 10.1016/j.yjmcc.2005.10.007
88. Störk S., Baumann K., von Schacky C., Angerer P., The effect of 17 β -estradiol on MCP-1 serum levels in postmenopausal women. Cardiovascular Research 2002 53 3 642 649 2-s2.0-0037083957 10.1016/S0008-6363(01)00461-8
89. Störk S., von Schacky C., Angerer P., The effect of 17 β -estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis 2002 165 2 301 307 2-s2.0-0036890084 10.1016/S0021-9150(02)00242-3
90. Arenas I. A., Armstrong S. J., Xu Y., Davidge S. T., Tumor necrosis factor- α and vascular angiotensin II in estrogen-deficient rats. Hypertension 2006 48 3 497 503 2-s2.0-33747391949 10.1161/01.HYP.0000235865. 03528.f1
91. Faulds M. H., Zhao C., Dahlman-Wright K., Gustafsson J. A., The diversity of sex steroid action: regulation of metabolism by estrogen signaling. Journal of Endocrinology 2012 212 1 3 12
92. Louet J. F., LeMay C., Mauvais-Jarvis F., Antidiabetic actions of estrogen: insight from human and genetic mouse models. Current Atherosclerosis Reports 2004 6 3 180 185 2-s2.0-3142550827
93. Bonds D. E., Lasser N., Qi L., Brzyski R., Caan B., Heiss G., Limacher M. C., Liu J. H., Mason E., Oberman A., O'Sullivan M. J., Phillips L. S., Prineas R. J., Tinker L., The effect of conjugated equine oestrogen on diabetes incidence: the women's health initiative randomised trial. Diabetologia 2006 49 3 459 468 2-s2.0-33244469258 10.1007/s00125-005-0096-0
94. Margolis K. L., Bonds D. E., Rodabough R. J., Tinker L., Phillips L. S., Allen C., Bassford T., Burke G., Torrens J., Howard B. V., Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the women's health initiative hormone trial. Diabetologia 2004 47 7 1175 1187 2-s2.0-4143116880
95. Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix A. Z., Kooperberg C., Stefanick M. L., Jackson R. D., Beresford S. A. A., Howard B. V., Johnson K. C., Kotchen J. M., Ockene J., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. The Journal of the American Medical Association 2002 288 3 321 333 2-s2.0-0037125379
96. Furberg C. D., Vittinghoff E., Davidson M., Herrington D. M., Simon J. A., Wenger N. K., Hulley S., Subgroup interactions in the heart and estrogen/progestin replacement study: lessons learned. Circulation 2002 105 8 917 922 2-s2.0-0037176920 10.1161/hc0802.104280
97. Manson J. A. E., Hsia J., Johnson K. C., Rossouw J. E., Assaf A. R., Lasser N. L., Trevisan M., Black H. R., Heckbert S. R., Detrano R., Strickland O. L., Wong N. D., Crouse J. R., Stein E., Cushman M., Estrogen plus progestin and the risk of coronary heart disease. The New England Journal of Medicine 2003 349 6 523 534 2-s2.0-0042093742 10.1056/NEJMoa030808
98. Stamataki K. E., Spina J., Rangou D. B., Chlouverakis C. S., Piaditis G. P., Ovarian function in women with non-insulin dependent diabetes mellitus. Clinical Endocrinology 1996 45 5 615 621 2-s2.0-0029826077
99. Ding E. L., Song Y., Malik V. S., Liu S., Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. The Journal of the American Medical Association 2006 295 11 1288 1299 2-s2.0-33644981693 10.1001/jama.295.11.1288
100. Harman S. M., Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gender Medicine 2006 3 4 254 269 2-s2.0-34250355937 10.1016/S1550-8579(06)80214-7
101. Kim J., Kim J. Y., Song K. S., Lee Y. H., Seo J. S., Jelinek J., Goldschmidt-Clermont P. J., Issa J. P. J., Epigenetic changes in estrogen receptor β gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochimica et Biophysica Acta 2007 1772 1 72 80 2-s2.0-33845647686 10.1016/j.bbadis.2006.10.004
102. Novensa L., Novella S., Medina P., Segarra G., Castillo N., Aging negatively affects estrogens-mediated effects on nitric oxide bioavailability by shifting ER α /ER β balance in female mice. PLoS ONE 2011 6 9 e25335
103. Novella S., Heras M., Hermenegildo C., Dantas A. P., Effects of Estrogen on vascular inflammation: a matter of timing. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 8 2035 2042
104. Ortmann J., Veit M., Zingg S., Di Santo S., Traupe T., Yang Z., Völzmann J., Dubey R. K., Christen S., Baumgartner I., Estrogen receptor- α but not-β or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK. Journal of Clinical Endocrinology and Metabolism 2011 96 1 220 228 2-s2.0-78650874327 10.1210/jc.2010-0943
105. Cignarella A., Bolego C., Pelosi V., Meda C., Krust A., Pinna C., Gaion R. M., Vegeto E., Maggi A., Distinct roles of estrogen receptor- α and β in the modulation of vascular inducible nitric-oxide synthase in diabetes. Journal of Pharmacology and Experimental Therapeutics 2009 328 1 174 182 2-s2.0-59149095338 10.1124/jpet.108.143511
106. Cignarella A., Minici C., Bolego C., Pinna C., Sanvito P., Gaion R. M., Puglisi L., Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutrition, Metabolism and Cardiovascular Diseases 2006 16 5 322 329 2-s2.0-33745610057 10.1016/j.numecd.2005.05.010
107. Nilsson S., Gustafsson J. A., Estrogen receptors: therapies targeted to receptor subtypes. Clinical Pharmacology and Therapeutics 2011 89 1 44 55 2-s2.0-78650446029 10.1038/clpt.2010.226
108. Barros R. P., Gustafsson J. A., Estrogen receptors and the metabolic network. Cell Metabolism 14 3 289 299 10.1016/j.cmet.2011.08.005